Dicot Pharma AB (STO: DICOT)
Sweden
· Delayed Price · Currency is SEK
0.229
0.00 (0.00%)
At close: Nov 22, 2024
Dicot Pharma AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
Cash & Equivalents | 130.4 | 47.34 | 9.38 | 30.33 | 20.33 | 12.22 | Upgrade
|
Cash & Short-Term Investments | 130.4 | 47.34 | 9.38 | 30.33 | 20.33 | 12.22 | Upgrade
|
Cash Growth | 190.73% | 404.88% | -69.08% | 49.20% | 66.30% | 34.73% | Upgrade
|
Other Receivables | 3.3 | 2.3 | 1.14 | 1.01 | 0.9 | 0.6 | Upgrade
|
Receivables | 3.3 | 2.3 | 1.14 | 1.01 | 0.9 | 0.6 | Upgrade
|
Inventory | 7.1 | 3.4 | 1.49 | - | - | 0.44 | Upgrade
|
Prepaid Expenses | - | 0.5 | 0.34 | 0.4 | 0.34 | 0.74 | Upgrade
|
Total Current Assets | 140.8 | 53.54 | 12.35 | 31.74 | 21.57 | 14.01 | Upgrade
|
Property, Plant & Equipment | - | 0.01 | 0.02 | 0.03 | 0.04 | - | Upgrade
|
Long-Term Accounts Receivable | - | - | - | - | - | 0.06 | Upgrade
|
Total Assets | 140.8 | 53.56 | 12.37 | 31.77 | 21.61 | 14.07 | Upgrade
|
Accounts Payable | - | 4.54 | 3.42 | 2.58 | 1.49 | 0.62 | Upgrade
|
Accrued Expenses | - | 3.98 | 1.19 | 0.66 | 0.37 | 0.55 | Upgrade
|
Other Current Liabilities | 8.4 | 0.64 | 2.41 | 0.19 | 0.09 | 0.11 | Upgrade
|
Total Current Liabilities | 8.4 | 9.16 | 7.01 | 3.42 | 1.95 | 1.27 | Upgrade
|
Total Liabilities | 8.4 | 9.16 | 7.01 | 3.42 | 1.95 | 1.27 | Upgrade
|
Common Stock | 12.5 | 5.72 | 17.14 | 12.86 | 5.46 | 2.05 | Upgrade
|
Additional Paid-In Capital | - | 180.76 | 86.15 | 81.67 | 53.2 | 32.22 | Upgrade
|
Retained Earnings | - | -142.09 | -97.93 | -66.18 | -39 | -21.46 | Upgrade
|
Shareholders' Equity | 132.4 | 44.39 | 5.36 | 28.35 | 19.66 | 12.8 | Upgrade
|
Total Liabilities & Equity | 140.8 | 53.56 | 12.37 | 31.77 | 21.61 | 14.07 | Upgrade
|
Net Cash (Debt) | 130.4 | 47.34 | 9.38 | 30.33 | 20.33 | 12.22 | Upgrade
|
Net Cash Growth | 190.73% | 404.88% | -69.08% | 49.20% | 66.30% | 34.73% | Upgrade
|
Net Cash Per Share | 0.16 | 0.09 | 0.08 | 0.47 | 0.71 | 1.23 | Upgrade
|
Filing Date Shares Outstanding | 1,779 | 817.56 | 137.1 | 102.9 | 43.67 | 16.36 | Upgrade
|
Total Common Shares Outstanding | 1,779 | 817.56 | 137.1 | 102.9 | 43.67 | 16.36 | Upgrade
|
Working Capital | 132.4 | 44.38 | 5.34 | 28.32 | 19.62 | 12.74 | Upgrade
|
Book Value Per Share | 0.01 | 0.05 | 0.04 | 0.28 | 0.45 | 0.78 | Upgrade
|
Tangible Book Value | 12.5 | 44.39 | 5.36 | 28.35 | 19.66 | 12.8 | Upgrade
|
Tangible Book Value Per Share | 0.01 | 0.05 | 0.04 | 0.28 | 0.45 | 0.78 | Upgrade
|
Machinery | - | 0.04 | 0.04 | 0.04 | 0.04 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.